Dried influenza vaccines: Over the counter vaccines

Human Vaccines

Volumn 6, Issue 10, 2010, Pages 854-856

  Saluja, V ^a   Hinrichs, W L J ^a   Frijlink, H W ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Influenza vaccine; Mucosal delivery; Sugar glass technology

Indexed keywords

INFLUENZA VACCINE; NON PRESCRIPTION DRUG; OVER THE COUNTER VACCINE; UNCLASSIFIED DRUG; VIROSOME;

DRUG DELIVERY SYSTEM; DRUG STABILITY; FREEZE DRYING; HUMAN; IMMUNOGENICITY; INFLUENZA VACCINATION; LACTOCOCCUS LACTIS; NOTE; PANDEMIC INFLUENZA; PHARMACEUTICS; SUGAR GLASS TECHNOLOGY;

CHEMISTRY, PHARMACEUTICAL; DRUG STABILITY; FREEZE DRYING; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; NONPRESCRIPTION DRUGS;

EID: 78649377836     PISSN: 15548600     EISSN: 15548619     Source Type: Journal    
DOI: 10.4161/hv.6.10.12572     Document Type: Note

References (25)

1. Coenen F, Tolboom JT, Frijlink HW. Stability of influenza sub-unit vaccine. Does a couple of days outside the refrigerator matter? Vaccine 2006; 24:525-31.
2. Amorij JP, Huckriede A, Wilschut J, Frijlink HW, Hinrichs WL. Development of stable influenza vaccine powder formulations: challenges and possibilities. Pharm Res 2008; 25:1256-73.
3. Molina MC, Armstrong TK, Zhang Y, Patel MM, Lentz YK, Anchordoquy TJ. The stability of lyophilized lipid/DNA complexes during prolonged storage. J Pharm Sci 2004; 93:2259-73. (Pubitemid 39129624)
4. Carpenter JF, Crowe JH. An infrared spectroscopic study of the interactions of carbohydrates with dried proteins. Biochemistry 1989; 28:3916-22.
5. Allison SD, Molina MC, Anchordoquy TJ. Stabilization of lipid/DNA complexes during the freezing step of the lyophilization process: the particle isolation hypothesis. Biochim Biophys Acta 2000; 1468:127-38.
6. Saluja V, Amorij JP, Kapteyn JC, de Boer AH, Frijlink HW, Hinrichs WL. A comparison between spray drying and spray freeze drying to produce an influenza subunit vaccine powder for inhalation. J Control Release 2010; 144:127-33.
7. Crowe LM, Crowe JH, Rudolph A, Womersley C, Appel L. Preservation of freeze-dried liposomes by trehalose. Arch Biochem Biophys 1985; 242:240-7.
8. Crowe JH, Crowe LM, Oliver AE, Tsvetkova N, Wolkers W, Tablin F. The trehalose myth revisited: introduction to a symposium on stabilization of cells in the dry state. Cryobiology 2001; 43:89-105.
9. Hinrichs WL, Prinsen MG, Frijlink HW. Inulin glasses for the stabilization of therapeutic proteins. Int J Pharm 2001; 215:163-74.
10. Amorij JP, Meulenaar J, Hinrichs WL, Stegmann T, Huckriede A, Coenen F, et al. Rational design of an influenza subunit vaccine powder with sugar glass technology: preventing conformational changes of haemagglutinin during freezing and freeze-drying. Vaccine 2007; 25:6447-57.
11. Maa YF, Ameri M, Shu C, Payne LG, Chen D. Influenza vaccine powder formulation development: spray-freeze-drying and stability evaluation. J Pharm Sci 2004; 93:1912-23. (Pubitemid 38823716)
12. de Jonge J, Amorij JP, Hinrichs WL, Wilschut J, Huckriede A, Frijlink HW. Inulin sugar glasses preserve the structural integrity and biological activity of influenza virosomes during freeze-drying and storage. Eur J Pharm Sci 2007; 32:33-44.
13. Geeraedts F, Saluja V, ter Veer W, Amorij JP, Frijlink HW, Wilschut J, et al. Preservation of the immunogenicity of dry-powder influenza H5N1 whole inactivated virus vaccine at elevated storage temperatures. AAPS J 2010; 12:215-22.
14. Huang J, Garmise RJ, Crowder TM, Mar K, Hwang CR, Hickey AJ, et al. A novel dry powder influenza vaccine and intranasal delivery technology: induction of systemic and mucosal immune responses in rats. Vaccine 2004; 23:794-801.
15. Kim YC, Quan FS, Compans RW, Kang SM, Prausnitz MR. Stability Kinetics of Inf luenza Vaccine Coated onto Microneedles During Drying and Storage. Pharm Res.
16. Tamura S, Kurata T. Defense mechanisms against influenza virus infection in the respiratory tract mucosa. Jpn J Infect Dis 2004; 57:236-47. (Pubitemid 40260238)
17. Amorij JP, Saluja V, Petersen AH, Hinrichs WL, Huckriede A, Frijlink HW. Pulmonary delivery of an inulin-stabilized influenza subunit vaccine prepared by spray-freeze drying induces systemic, mucosal humoral as well as cell-mediated immune responses in BALB/c mice. Vaccine 2007; 25:8707-17. (Pubitemid 350199597)
18. Renegar KB, Small PA Jr, Boykins LG, Wright PF. Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract. J Immunol 2004; 173:1978-86.
19. Liew FY, Russell SM, Appleyard G, Brand CM, Beale J. Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity. Eur J Immunol 1984; 14:350-6.
20. Moldoveanu Z, Clements ML, Prince SJ, Murphy BR, Mestecky J. Human immune responses to influenza virus vaccines administered by systemic or mucosal routes. Vaccine 1995; 13:1006-12.
21. Mestecky J, Russell MW, Elson CO. Perspectives on mucosal vaccines: is mucosal tolerance a barrier? J Immunol 2007; 179:5633-8.
22. Vidgren MT, Kublik H. Nasal delivery systems and their effect on deposition and absorption. Adv Drug Deliv Rev 1998; 29:157-77.
23. Bakke H, Samdal HH, Holst J, Oftung F, Haugen IL, Kristoffersen AC, et al. Oral spray immunization may be an alternative to intranasal vaccine delivery to induce systemic antibodies but not nasal mucosal or cellular immunity. Scand J Immunol 2006; 63:223-31. (Pubitemid 43356784)
24. Dean HJ, Chen D. Epidermal powder immunization against influenza. Vaccine 2004; 23:681-6.
25. Quan FS, Kim YC, Yoo DG, Compans RW, Prausnitz MR, Kang SM. Stabilization of influenza vaccine enhances protection by microneedle delivery in the mouse skin. PLoS One 2009; 4:7152.